Quanta Pharma Tirzepatide 30mg + Free BAC Water

Description

Quanta Pharma Tirzepatide 30mg

Tirzepatide is a dual agonist: one molecule acts on both the GLP-1 and GIP receptors. The Quanta Pharma version is a lyophilised 30mg vial and comes with bacteriostatic water for reconstitution.

What the research covers

Acting on both receptors improves insulin release when blood sugar is high, lowers glucagon, slows stomach emptying and reduces appetite. Research covers blood sugar control, body weight and body composition. The half-life of around five days suits once-weekly research protocols.

Where the evidence sits

Tirzepatide has a strong clinical evidence base and is a licensed medicine (Mounjaro) for type 2 diabetes and weight management. In the SURMOUNT-1 trial, the highest dose produced an average 20.9% reduction in body weight at 72 weeks. Those results come from the licensed pharmaceutical product. This vial is not that product and is supplied strictly as a laboratory research chemical.

The vial format

• 30mg tirzepatide per vial
• Lyophilised (freeze-dried) powder in a sealed glass vial with a rubber stopper
• Reconstitute with bacteriostatic water, run slowly down the inside wall of the vial
• Swirl gently until clear. Do not shake
• Bacteriostatic water is included free with every vial

Handling and storage

• Store sealed vials refrigerated at 2–8°C, away from direct light.
• Once reconstituted, keep refrigerated at 2–8°C and use within 28 days.
• Do not freeze a reconstituted vial.
• Swab the stopper with an alcohol wipe before every draw.
• Keep out of reach of children and animals.

What is in the box

• 1 × Quanta Pharma Tirzepatide 30mg vial
• 1 × 3ml bacteriostatic water (free)

Supplied strictly as a laboratory research chemical. Not licensed as a medicine in the UK or anywhere else. Not for human or veterinary use. The research cited covers animal and in vitro work unless otherwise stated.